Lepirudin

In the US, Lepirudin (lepirudin systemic) is a member of the drug class thrombin inhibitors and is used to treat Thrombocytopenia Drug Induced.

US matches:

• Lepirudin


• Lepirudin Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B01AE02

CAS registry number (Chemical Abstracts Service)

0138068-37-8

Chemical Formula

C287-H440-N80-O111-S6

Molecular Weight

6979

Therapeutic Category

Anticoagulant agent: Direct thrombin inhibitor

Chemical Name

1-L-Leucine-2-L-threonine-63-desulfohirudin (Hirudo medicinalisisoform HV1)

Foreign Names

• Lepirudinum (Latin)
• Lepirudin (German)
• Lepirudine (French)
• Lepirudina (Spanish)

Generic Names

• Lepirudin (OS: BAN)
• HBW 023 (IS: Chiron Behring)
• rDNA-Hirudin (IS)

Brand Names

• Refludan
  Bayer, Canada; Bayer, United States; Berlex, United States; Celgene, Belgium; Celgene, Switzerland; Celgene, Germany; Celgene, United Kingdom; Celgene, Sweden; Pharmion, Austria; Pharmion, Australia; Pharmion, France; Pharmion, Hungary; Pharmion, Ireland; Pharmion, Luxembourg; Pharmion, Netherlands; Pharmion, Norway; Schering, Italy



• Refludin
  Key Oncologics, South Africa; Pharmion, Spain

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.